IBIO vs MKTX · rev $100.0K vs P/E 13, rev $451.8M
iBio, Inc. Common Stock (IBIO) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
IBIO currently screens at market cap $13.4M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the IBIO and MKTX stock pages for the full models.
Not investment advice.